Accelerate Diagnostics Q4 EPS $(0.89) Misses $(0.62) Estimate, Sales $3.03M Miss $3.45M Estimate

Accelerate Diagnostics, Inc. -9.38%

Accelerate Diagnostics, Inc.

AXDX

1.16

-9.38%

Accelerate Diagnostics (NASDAQ: AXDX) reported quarterly losses of $(0.89) per share which missed the analyst consensus estimate of $(0.62) by 43.55 percent. This is a 493.33 percent decrease over losses of $(0.15) per share from the same period last year. The company reported quarterly sales of $3.03 million which missed the analyst consensus estimate of $3.45 million by 12.26 percent. This is a 1.85 percent increase over sales of $2.97 million the same period last year.
Every question you ask will be answered
Scan the QR code to contact us
whatsapp
Also you can contact us via